InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Najat Khan, Chief R&D Commercial Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 3 open-market SEC Form 4 transactions: 0 purchases worth $0 and 3 sales worth $845K, reported from Aug 18, 25 to Mar 9, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 26 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 28.3K | $3.35 | $95K |
| Dec 22, 25 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 124.4K | $4.41 | $549K |
| Aug 18, 25 | RXRXRECURSION PHARMACEUTICALS, INC. | SELL | 36.6K | $5.52 | $202K |